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Abstract
Background Choice of a multi-attribute utility instrument
(MAUI) that appropriately assesses an intervention’s
health-related quality-of-life (HRQoL) impacts is a vital
part of healthcare resource allocation and clinical
assessment.
Objective Our exploratory study compared the EuroQol
(EQ)-5D-5L and Assessment of Quality of Life (AQoL)-
8D MAUIs, which were used to assess the effect of bar-
iatric surgery for a cohort of long-term publicly waitlisted,
severely obese patients.
Methods The study was conducted at the Hobart Private
Hospital (Tasmania, Australia). To compare the sensitivity
and instrument content of the two MAUIs, we used
dimensional comparisons by investigating the distribution
of patient-reported responses (number/percentage) across
the MAUIs’ levels and dimensions; summary health-state
utility valuations (utilities); and individual/super-dimen-
sion scores (AQoL-8D) to investigate discriminatory power
and HRQoL improvements preoperatively and 3 months
postoperatively.
Results Participants’ (n = 23) overall MAUI completion
rate was 74%. Postoperative total weight loss was 9.9%.
EQ-5D-5L utilities were relatively higher pre- and post-
operatively than AQoL-8D utilities [mean standard devia-
tion (SD) EQ-5D-5L 0.70 (0.25) to 0.80 (0.25); AQoL-8D
0.51 (0.24) to 0.61 (0.24)]. AQoL-8D Psychosocial super
dimension was relatively low postoperatively [0.37 (0.25)],
driving the instrument’s lower utility. These results were
supported by the dimensional comparisons that revealed an
overall greater dispersion for the AQoL-8D. Nevertheless,
there were clinical improvements in utilities for both
instruments. AQoL-8D utilities were lower than population
norms; not so the EQ-5D-5L utilities. The AQoL-8D
dimensions of Happiness, Coping, and Self-worth
improved the most.
Conclusions AQoL-8D more fully captured the impact of
obesity and bariatric surgery on HRQoL (particularly
psychosocial impacts) for long-term waitlisted bariatric
surgery patients, even 3 months postoperatively. AQoL-8D
preoperative utility revealed our population’s HRQoL was
lower than people with cancer or heart disease.
Electronic supplementary material The online version of this
article (doi:10.1007/s41669-017-0060-1) contains supplementary
material, which is available to authorized users.
& Andrew J. Palmer
Andrew.Palmer@utas.edu.au
1 Menzies Institute for Medical Research, University of
Tasmania, Medical Sciences 2 Building, 17 Liverpool Street,
Hobart, TAS 7000, Australia
2 Department of Health and Human Services, Level 2, 22
Elizabeth Street, Hobart, TAS 7000, Australia
3 Royal Hobart Hospital, 48 Liverpool Street, Hobart, TAS
7000, Australia
PharmacoEconomics Open (2018) 2:443–458
https://doi.org/10.1007/s41669-017-0060-1
Key Points for Decision Makers
The Assessment of Quality of Life (AQoL)-8D may
have superior discriminatory sensitivity compared to
the EuroQol (EQ)-5D-5L for long-term waitlisted
severely obese bariatric surgery patients.
There is potential for sub-optimal healthcare
resource allocation if the selected multi-attribute
utility instrument does not appropriately assess
health-related quality-of-life (HRQoL) impacts for
the bariatric surgery study population.
As an important and increasingly prevalent study
population of bariatric surgery patients who
inherently carry complex physical and psychosocial
HRQoL needs, long-term waitlisted severely obese
bariatric surgery patients showed improvements in
HRQoL even 3 months postoperatively.
1 Introduction
Demand for publicly funded bariatric care in many coun-
tries is high; however, capacity is limited by healthcare
funding decisions. Consequently, bariatric (metabolic,
obesity or weight-loss) surgery waiting lists are long [1, 2].
Prolonged delays generally exist for people waitlisted for
primary bariatric surgery in public health systems in many
countries, including Australia [3–5].
Whilst it is acknowledged that these protracted multi-
year wait times are detrimental to the bariatric surgery
candidate’s physical and psychosocial health [2, 6, 7],
recent evidence has established that weight status is just
one factor contributing to the complex health-related
quality-of-life (HRQoL) needs of people who have
received bariatric surgery [8, 9]. Nevertheless, there is a
paucity of quantitative evidence regarding HRQoL impacts
for long-term waitlisted bariatric surgery patients who have
experienced multiyear wait times on public waiting lists
and then undergo bariatric surgery [10, 11].
Multi-attribute utility instruments (MAUIs) are a
HRQoL assessment tool designed to rapidly and conve-
niently assess and capture an individual’s health-state
utility values through application of pre-established for-
mulae/weights to the array of responses obtained on the
MAUI’s questionnaire [9]. A MAUI is developed and
defined with particular characteristics, including the num-
ber of questionnaire items; the depth and breadth of the
descriptive/classification system; the number of health
states described; the number of individual and super
dimensions (if there are super dimensions); and the algo-
rithmic range.
For example, the number of health states described for
the EuroQol (EQ)-5D-3L and 5L, Health Utilities Index
(HUI) 3, 15D, Short-Form 6 Dimension (SF-6D), Quality
of Well-Being (QWB) and Assessment of Quality of Life
(AQoL)-8D MAUIs range from 243; 3125; 972,000;
3.1 9 1010; 18,000; 945; and 2.4 9 1023, respectively [12].
Additionally, many MAUIs target physical health within
their descriptive/classification systems. For example, for
the EQ-5D-5L, one of its five dimensions relates to psy-
chosocial health (Anxiety/Depression) and four out of five
relate to physical health (Mobility, Self-care, Usual
Activities and Pain) [13]. In contrast, for the AQoL-8D,
three of the instrument’s eight dimensions relate to physi-
cal health (Independent Living, Senses and Pain), and five
of the eight dimensions relate to psychosocial health
(Coping, Relationships, Self-worth, Happiness and Mental
Health), and 25 of the 35 items (questions) inform the
AQoL-8D’s five psychosocial dimensions [14, 15]. The
SF-6D describes six dimensions, namely Physical Func-
tioning, Role Limitations, Social Functioning, Pain, Mental
Health and Vitality [12, 16]. Both the AQoL-8D and SF-6D
describe composite physical and psychosocial dimensions,
namely the Physical and Psychosocial super dimensions
(AQoL-8D), and the Physical and Mental Component
Summaries (SF-6D) [14, 17].
A small number of MAUIs dominate the economic
evaluation literature. These include the EQ-5D-3L (pre-
cursor to the EQ-5D-5L), HUI 3 and SF-6D. A review of
1663 studies between 2005 and 2010 found that these three
instruments accounted for 63, 9.9, and 8.8% of the total,
respectively [12]. Four other instruments in the review, the
15D, HUI 2, AQoL, and QWB, were used in 7, 4.6, 4.2,
and 2.5% of the studies, respectively [18].
A recent cross-sectional study of patients who had
received bariatric surgery in the private healthcare system
many years previously [median [interquartile range (IQR)]
5 (3–8) years] found that the AQoL-8D and EQ-5D-5L
instruments were not interchangeable for the study popu-
lation [9]. Another recent study that investigated the 1-year
health impacts for long-term waitlisted bariatric surgery
patients (and complementary to this study using the same
cohort of patients), suggested that the AQoL-8D prefer-
entially captured HRQoL for the study population 1 year
after surgery [11]. Importantly, this 1-year study did not
directly compare the distributions of patient-reported
responses across the depth and breadth of the MAUIs’
dimensions of health (dimensional comparisons) [11]. As a
single MAUI instrument, the AQoL-8D captures the vast
majority of domains considered crucial for people who are
considering, or who have undergone, bariatric surgery [9].
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The choice of MAUI should be influenced by the sen-
sitivity of the instrument to a patient group’s health profile
[9, 12]. If the choice of instrument does not appropriately
capture and assess the individual’s and study population’s
health profiles (particularly for complex physical and
psychosocial HRQoL), vital healthcare information about a
clinical intervention’s health impact will be omitted from
important resource allocation and planning decisions [9].
Utility valuations are key health economic metrics that
are an input measure in the assessment of quality-adjusted
life years (QALYs) [19]. Utility valuations measure the
strength of preference for a particular health state and are
represented as a number on a scale where 1.0 represents the
best possible health state and 0.0 represents death. In
principle, values less than zero are possible when a health
state is worse than death [20]. Utility values assessed by
MAUIs are not equivalent, with the difference between the
descriptive/classification systems of the MAUIs the prin-
cipal determinant [12]. Additionally, differences in
descriptive/classification systems are estimated to explain
an average of 66% of the difference between utilities
obtained by MAUIs, and 81% of the difference between the
utilities of the EQ-5D-5L and AQoL-8D [12].
MAUIs were not initially developed for clinical use;
however, utility valuations can also be used to inform and/
or predict clinical outcomes [21]. Clinicians have found
that measuring utilities is of benefit to patient–clinical
assessment, relationships, communication, and manage-
ment [22]. Many MAUIs (including the EQ-5D-5L and 3L,
AQoL-4D, SF-6D, 15D and HUI) report minimal clinically
important differences or minimal important differences for
their utility valuations [23–28]. A minimal clinically
important difference is the smallest difference in score in
the outcome of interest that patients perceive as beneficial
and which would mandate a clinical change in the patient’s
management (both individually and collectively for a par-
ticular study population) [22, 23, 29, 30].
There is a paucity of evidence regarding short-term
HRQoL impacts for people who have received bariatric
surgery [31, 32]. A study published in 2007 provided
3-month (range 3–6 months) HRQoL impacts of bariatric
surgery using the SF-36 [33]. A second study published in
2001 provided 1-, 3- and 6-month HRQoL impacts of
bariatric surgery using the SF-36, bariatric analysis and
reporting outcome system (BAROS) and Moorhead-Ardelt
quality-of-life questionnaires [34]. Both studies found
short-term improvements in the quality of life scores
(however, these studies did not generate, nor investigate,
utility valuations) after bariatric surgery.
Whilst it is acknowledged that integrating patient-re-
ported outcomes (PROs) in clinical practice has the
potential to enhance patient-centred care [35], PROs are
not yet routinely collected in bariatric care. A recent
systematic review that identified and investigated
prospective bariatric surgery studies that used validated
PRO measures found that for PRO data to influence prac-
tice, well-designed and reported studies are required [36].
In turn, there is a potential for MAUIs to address this key
gap regarding PROs in bariatric care subject to the par-
ticular MAUI’s capacity to capture, assess and describe the
relevant health states of the study population.
The main objective of this exploratory study was to
directly compare the discriminatory power of two different
MAUIs, namely the EQ-5D-5L and the AQoL-8D, which
were used to assess the effect of bariatric surgery using a
cohort of long-term publicly waitlisted, severely obese
patients who underwent bariatric surgery as part of a
government policy initiative to reduce waiting lists. As a
secondary objective, we also aimed to investigate the role
of the two MAUIs in the analysis of individual patient
health states.
The EQ-5D suite of instruments dominates the clinical
and economic literature, including that for bariatric surgery
[14, 18]. Nevertheless, the AQoL-8D has been shown to
have preferential psychometric properties compared to
comparative MAUIs in study populations where the
assessment of psychosocial health status is crucial, for
example, intensive care unit (ICU) admissions (compared
with SF-6D) [22] and people who had undergone bariatric
surgery (compared with the EQ-5D-5L) [9, 11]. Addi-
tionally, a recent study that presented results from one of
the broadest comparative surveys in terms of the range of
diseases (arthritis, asthma, cancer, depression, diabetes,
hearing loss and heart disease) and six MAUIs (EQ-5D-5L,
SF-6D, HUI 3, 15D, QWB and AQoL-8D), and countries
(Australia, the USA, the UK, Canada, Norway, and Ger-
many) found that the AQoL-8D is the most sensitive
instrument for measuring mental health [37]. This study
also found that the pain component of the EQ-5D-5L has a
greater impact than it does in any other instrument, and that
the EQ-5D-5L is the most sensitive instrument for mea-
suring pain [37].
Our exploratory study also investigated the relative
magnitudes of the global utility valuations [12], clinical
improvements of the utility valuations for both instruments,
and also the impacts on individual domains of health
through the AQoL-8D’s individual and super-dimension
scores.
In parallel with our previously published study that
investigated the 1-year health impacts in long-term wait-
listed patients [11], this current study aimed to investigate
the distribution of the patient-reported responses of the two
MAUIs for this population of public healthcare long-
waiting bariatric surgery patients who inherently carry
complex physical and psychosocial HRQoL needs.
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2 Methods
2.1 Study Design
2.1.1 Recruitment of Participants
Recruitment of our study participants is described in detail
in our previously published study [11]. In summary, a
Tasmanian government policy decision was made in 2014
to allocate additional and targeted public funds to provide
morbidly obese, long-term waitlisted patients with bariatric
surgery in 2015 [38]. All participants underwent laparo-
scopic adjustable gastric band (LAGB) surgery by the same
surgeon in the Hobart Private Hospital. Laparoscopic
banding was carried out using Apollo APS or APL bands,
with adjustment ports attached to the left anterior rectus
sheath [39]. Postoperative fluid diets were maintained for
3 weeks, with subsequent transition to normal foods,
accompanied by instruction on eating technique and
exercise.
All data were de-identified. Ethics approval was granted
by the University of Tasmania’s Health and Medical
Human Research Ethics Committee (HMHREC) before our
study’s recruitment of participants.
2.1.2 The Multi-attribute Utility Instruments
and Questionnaire Completion
The selection and attributes of the EQ-D-5L and AQoL-8D
MAUIs used in this study have previously been described
in detail [11]. Another earlier study comparing the EQ-5D-
5L and the AQoL-8D MAUIs for people who had under-
gone LAGB surgery many years previously provided a
detailed summary of the divergent characteristics of the
two purposively selected MAUIs [9, 11]. In summary, the
two markedly different MAUIs were selected on the fol-
lowing basis: the EQ-5D-5L is the internationally prevalent
instrument in economic evaluation (including the economic
evaluation of bariatric surgery) [40]; four of the five
instrument’s health domains/classifications (and items)
focus on physical HRQoL; and it takes less than 1 min to
complete the EQ-5D-5L’s questionnaire [13]. The EQ-5D-
5L also contains a visual analogue scale (EQ-VAS) [22]. In
contrast, the AQoL-8D’s classification system is supported
by psychometric principles and testing, and 25 of the
instrument’s 35 items capture and assess five (from eight)
psychosocial domains of health, and three physical
domains of health. The AQoL-8D describes billions of
health states and takes 5 min to complete [14, 15, 41].
Participants were asked to self-complete both instru-
ments’ questionnaires before their bariatric surgery at the
pre-admission preoperative clinics and at 3 months
postoperatively. Postoperative questionnaires were mailed
out for self-completion with an explanatory cover letter and
reply-paid envelope enclosed. We evaluated EQ-5D-5L
and AQoL-8D questionnaire completion by assessing the
overall proportion of participants who completed the
questionnaire(s) at the study’s two time points for whom an
individual utility value could be generated.
2.2 Data Analysis
Participants with patient-reported HRQoL assessments for
one or both instruments, for at least one time point where
the MAUI algorithm (either instrument) could generate the
instrument’s utility valuations or scores were included in
the analyses.
Descriptive baseline socio-demographic, clinical data,
utility valuations and dimensional scores were presented as
mean [standard deviation (SD)] and/or median (IQR) for
continuous variables and frequency (%) for categorical
variables. Body mass index (BMI) was calculated as
weight (kg)/[height (m2)] and classified as obese (BMI
30–34.9 kg/m2), severely obese (BMI 35–39.9 kg/m2),
morbidly obese (BMI 40–49.9 kg/m2), and super obese
(BMI C50 kg/m2) [42].
2.2.1 Discriminant Sensitivity: Dimensional Comparisons
(Both Instruments) and Dimensional Scores (AQoL-
8D)
The relative discriminatory power of the instruments was
investigated using two methodologies.
First, we calculated the distribution of participant
responses across the levels and dimensions (the depth and
breadth) of both instruments. This was achieved by col-
lating the participant-reported response for each item and
then calculating the percentage distribution of responses
for each dimension [9, 16]. To illustrate, for the EQ-5D-5L
individual dimension of Anxiety/Depression, the numbers
of participants who gave each response level (1, 2, 3, 4 or
5) were converted to a percentage of the total number of
participants in order to derive a ‘five-level frequency dis-
tribution’. Detailed calculations for each item and dimen-
sion are provided in Appendix 1 [see the electronic
supplementary material (ESM)]. Additionally, schematic
representations of the dimensional comparisons were
expressed as a percentage by calculating the average per-
centage before and after surgery. For example, the sche-
matic representation of the physical dimensions of both
instruments compared the average score of Mobility, Self-
care, Usual Activities and Pain for the EQ-5D-5L and
Independent Living, Sense and Pain for the AQoL-8D for
each level before and after surgery.
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Second, impacts on the individual domains of physical
and psychosocial HRQoL were investigated through the
AQoL-8D’s summary scores for the eight individual
dimensions and two super dimensions. The EQ-5D-5L
generates a single utility valuation for an individual;
however, it does not generate individual or summary scores
for each and every one of its five separate dimensions.
2.2.2 Analyses of Summary Utility Valuations and EQ-VAS
Scores
Utility valuations were generated for the EQ-5D-5L using
the most recent UK value based on directly elicited pref-
erences, the valuation ranging from - 0.281 to 1.0 utility
points [43, 44]. All five questions require a valid response
to generate a utility score. EQ-5D population norms are
sourced from UK data because there are no available
Australian population norms [45]. For the AQoL-8D, we
used the current version of the scoring algorithm incorpo-
rating Australian weights published on the AQoL group’s
website (http://www.aqol.com.au) (valuation range ? 0.09
to 1.0 utility points). For the AQoL-8D’s scoring algo-
rithm, an overall utility valuation can be generated with ten
missing values scattered over all dimensions. Australian
population norms were sourced from recently published
valuations [41]. Individual and super-dimensional scores
are also generated with the AQol-8D’s scoring algorithm.
A minimal clinically important difference (or minimal
important difference) is the smallest difference in score in
the outcome of interest which patients perceive as benefi-
cial and which would mandate a change in the patient’s
management [23, 29, 30]. A recently reported composite
minimal important difference for the EQ-5D-5L for
chronic health conditions was reported as 0.04 utility points
[46]. There is no established minimal important difference
for the AQoL-8D; however, a minimal important differ-
ence for the AQoL-4D has previously been reported as 0.06
utility points, with a 95% confidence interval of 0.03–0.08
utility points [24]. This study conservatively adopted the
upper bound of 0.08 utility points as the proxy minimal
important difference for comparison of the pre- and post-
operative AQoL-8D utility valuations. The established
minimal important difference for the EQ-VAS is 10 points
[47]. It has been suggested that with the expanded use of
HRQoL endpoints (for example, analyses of utility valua-
tions and scores within vastly different MAUI classification
systems), the interpretation of HRQoL in the context of
minimal important differences is imperative [23]. In turn,
our study has included the interpretation of minimal
important differences in its comparison of the EQ-5D-5L
and AQoL-8D MAUIs.
Statistical analyses were undertaken using IBM SPPS
(version 22) or R (version 3.0.2).
3 Results
3.1 Participants’ Characteristics and Questionnaire
Completion
Twenty-three participants were recruited to the study. For
these participants, mean (SD) age was 50 (10) years, 43%
were males, and mean (SD) and median (IQR) time on the
public waiting list for bariatric surgery was 6.5 (2.0) and
6.3 (5.0–7.8) years, respectively.
Table 1 provides pre- and postoperative results for BMI,
percentage total weight lost and percentage excess weight
lost. Before surgery 39% of participants were classified as
super obese (BMI C50 kg/m2) and 57% were classified as
morbidly obese (BMI 40–49.9 kg/m2). After surgery, there
was a 26% reduction in the super-obesity category. Simi-
larly, after surgery, the morbidly obese category was
reduced by 17%.
In regard to questionnaire completion, there was a 74%
completion rate of questionnaires overall [Tables 2, 3 and
4; Appendix 1 (see the ESM)].
3.2 Sensitivity: Dimensional Comparisons
The relative discriminatory power of the instruments was
investigated using the dimensional comparisons outlined in
Sect. 2.2.1.
Table 2 (supported by Appendix 1 in the ESM) presents
the ‘before’ and ‘after’ surgery distribution of participant
responses for both MAUIs’ 13 individual dimensions/do-
mains of health across levels 1–5 (EQ-5D-5L) and levels 1
through to 4, 5 or 6 (AQoL-8D). Figure 1a–c also provide a
schematic representation of the comparative distribution of
the participants’ responses across levels 1–6 for all
dimensions (Fig. 1a), and for the physical dimensions of
health for both instruments (EQ 5D-5L: Mobility, Self-
care, Usual Activities and Pain; AQoL-8D: Independent
Living, Senses and Pain) (Fig. 1b), and the psychosocial
dimensions of health for both instruments (EQ-5D-5L:
Anxiety/Depression; AQoL-8D: Coping, Mental Health,
Relationships, Self-worth, Happiness) (Fig. 1c).
None of the participants responded to level 6 for the
AQoL-8D items that provided for a level 6 response
[namely Independent Living (one item), Senses (two items:
vision and hearing), Mental Health (one item) and Rela-
tionships (one item)] (Table 2 and Appendix 1). Table 2
and Fig. 1a–c (supported by Appendix 1) revealed a more
even dispersion of participant responses for the AQoL-8D
than the EQ-5D-5L both pre- and postoperatively. The
AQoL-8D more clearly distinguished between health states
that are close to full health for the study population
(Table 2, Fig. 1a–c, Appendix 1).
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More specifically, postoperatively participants recorded
80% (76/95) of responses for the EQ-5D-5L at level 1
(perfect health: I have no problems) and level 2 (I have
slight problems), the highest recorded response at level 1
being 74% for Self-care (decreased from 81% before sur-
gery) (Table 2; Appendix 1). These results highlight the
EQ-5D-5L’s inability to distinguish between health states
close to full/perfect health (utility score 1.0). Additionally,
for the EQ-5D-5L’s only psychosocial dimension of health
(Anxiety/Depression), participants did not record responses
at level 4 (I am severely anxious or depressed), nor level 5
(I am extremely anxious or depressed), indicating that the
EQ-5D-5L’s only psychosocial dimension is relatively
limited. Before surgery, only 6% of participants recorded
both levels 4 and 5 for Anxiety/Depression (Table 2,
Appendix 1, and Fig. 1c). Participants recorded responses
at level 4 (16%) for one of the EQ-5D-5L’s individual
dimensions (Pain) after surgery (Table 2; Appendix 1).
In contrast, participants’ postoperative responses to the
AQoL-8D questionnaire were less concentrated in the
upper levels (i.e. more evenly dispersed across the levels),
with only 58% (365/630) of responses recorded at levels 1
and 2 (Table 2, Fig. 1a, and Appendix 1), the highest
recorded response at level 1 being 41% for Senses.
Participants also recorded responses at level 4 for all the
AQoL-8D’s individual dimensions, and participants also
recorded responses at level 5 for both Pain and Mental
Health. Additionally, the lowest percentage of participants
scored at level 1 for the AQoL-8D’s individual dimensions
of Happiness (15%), Coping (19%) and Mental Health
(26%) (Table 2; Appendix 1). Nevertheless, Happiness and
Coping substantially improved from before surgery to 3
months after surgery and approached population norms
(Table 3), and this result is also revealed with the
improvement of participants’ preoperative scores at level 1
in Happiness (from 3% to 15%) and Coping (from 11% to
19%) (Table 2; Appendix 1).
The individual dimension that had the most similar
distribution for both instruments across levels 1–5 was
Pain/Discomfort for the EQ-5D-5L (level 1: 26%, level 2:
32%, level 3: 26%, level 4: 16% and level 5: 0%) and Pain
for the AQoL-8D (level 1: 35%, level 2: 19%, level 3:
31%, level 4: 13% and level 5: 2%) (Table 2; Appendix 1).
Three of the 35 AQoL-8D items contribute to the dimen-
sion of Pain. These items capture and assess how often the
respondent suffers for the first Pain item ‘serious pain’, for
the second Pain item the severity of ‘pain or discomfort’,
and for the third Pain item of how often pain interferes with
usual activities. The EQ-5D-5L individual dimension of
Pain/Discomfort assesses the level of severity of pain/dis-
comfort (no pain/discomfort, slight, moderate, severe,
extreme).
3.3 Sensitivity: Comparison of Changes in Utility
Valuations
Table 4 provides summary statistics for the changes in both
instruments’ utility valuations preoperatively to 3 months
Table 1 Number of
participants (n = 23) in obesity
categories before and after
surgery
Before surgery After surgery* Change
BMI
Mean (SD) 49.3 (9.4) 43.5 (7.2) - 5.8
Median (IQR) 45.5 (41.6–55.4) 43.2 (38.7–49.6) - 2.3
BMI (n, %)
BMI C30–34.9 kg/m2 (class I) (1, 4%) (2, 9%) (? 1, ? 6%)
BMI C35–39.9 kg/m2 (class II) 0 (7, 30%) (? 7, ? 33%)
BMI C40–49.9 kg/m2 (class III) (13, 57%) (9, 39%) (- 4, - 17%)
BMI C50 kg/m2** (9, 39%) (3, 13%) (- 6, - 26%)
Weight (kg)
Mean (SD) 139.7 (31.4) 125.9 (26.9) - 13.8
Median (IQR) 134.0 (118.8–161.5) 124.5 (106.9–142.2) - 8.1
% Total weight lost
Mean (SD) NA 9.9 (6.2) NA
Median (IQR) NA 11.0 (3.7–15.0) NA
% Excess weight lost
Mean (SD) NA 21.5 (13.1) NA
Median (IQR) NA 24.7 (12.6–28.2) NA
BMI body mass index, IQR interquartile range, NA not applicable, SD standard deviation
*N = 21; 2 participants’ 3-month weight not available
**Super obese (C50 kg/m2)
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postoperatively. The EQ-5D-5L revealed relatively higher
summary utility valuations than the AQoL-8D both before
and after surgery. Specifically, the order of magnitude of
the EQ-5D-5L’s mean utility valuations were 0.19 utility
points greater than the mean AQoL-8D utility valuations
preoperatively and 3 months postoperatively. The AQoL-
8D particularly showed low summary utility valuations
before surgery [EQ-5D-5L 0.70 (0.25); AQoL-8D 0.51
(0.24)].
Three months after surgery, the summary utility valua-
tions revealed clinical improvements for both instruments.
Nonetheless, the AQoL-8D showed substantially lower
postoperative summary utility valuations than the EQ-5D-
5L. More specifically, the EQ-5D-5L utility value
increased by 0.10 points from mean (SD) 0.70 (0.25) to
0.80 (0.25). Similarly, the AQoL-8D utility value increased
by 0.10 points from 0.51 (0.24) to 0.61 (0.24) (Table 4).
After surgery, the EQ-5D-5L utility valuations approa-
ched comparable population norms, but not so the AQoL-
8D’s utility valuations. The UK general population mean
for the EQ-5D-5L is 0.86 [45], and for the AQoL-8D the
general Australian population norm is 0.80 (0.19), and for
the 45–54-year age group, it is 0.77 (0.20) [41] (Table 4).
Table 4 also provides mean (SD) pre- and postoperative
EQ-VAS scores of 57 (25) to 67 (24) points, the difference
equalling the established EQ-VAS minimal important
difference of 10 points.
3.4 AQoL-8D Individual/Super-Dimension Scores
Table 3 provides the AQoL-8D’s individual and super-di-
mension scores before surgery and 3 months after surgery,
and the Australian population norms at the individual
dimensional level for the general population and the
45–54-year age group. Additionally, Fig. 2a, b provide a
schematic representation of the individual and super-di-
mensional scores compared with the general Australian
population norm. The EQ-5D-5L does not generate indi-
vidual or super-dimension scores.
Improvements were observed for all eight individual
dimension scores and the two super-dimension scores even
3 months after surgery. Three months after surgery, the
Physical super dimension improved 0.05 points to mean
(SD) 0.56 (0.27) points and the Psychosocial super-di-
mension score improved 0.12 points to 0.37 (0.25) points.
Of the eight individual dimensional scores, Self-worth and
Happiness improved the most 3 months after surgery by
revealing gains of 0.11 points (Self-worth) and 0.10 points
(Happiness). The postoperative scores for Happiness 0.75
(0.15) and Coping 0.76 (0.15) also approached both the
45–54-year age group and general population norms.
Happiness was only 0.02 points less than the 45–54-year
age group population norm and Coping was only 0.04T
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points less than the 45–54-year age group population norm.
Other individual dimensional scores that improved by
C 0.05 points after surgery were Coping (0.09 points),
Mental Health (0.06 points) and Relationships (0.05
points), which contribute to the Psychosocial super
dimension. With regard to the Physical super dimension,
Independent Living and Pain both improved 0.06 points
and Senses showed a smaller improvement of 0.02 points
(Table 3).
As mentioned previously, the cohort’s HRQoL before
surgery was substantially lower in comparison to popula-
tion norms (Table 3; Fig. 2a, b). Individual dimensional
scores improved 3 months postoperatively, but did not
substantially approach Australian population norms, with
the exception of two dimensions: Happiness and Coping
(Table 3; Fig. 2a). The Psychosocial and Physical super
dimensions’ scores, while improved, were still substan-
tially lower than the Australian general population norm at
- 0.13 and - 0.27 points, respectively. The Physical super-
dimension score was driven by the Pain dimension scoring
0.24 points less than the general population norm. Inde-
pendent Living and Relationships also revealed large dif-
ferences, scoring - 0.19 and - 0.13 points from the general
population norm. Similarly, Mental Health/Self-worth and
Senses also revealed scores of 0.09/0.09 and 0.08 less than
their Australian general population norm equivalents,
respectively. In contrast, the individual dimensions of
Happiness and Coping approached both the general and
45–54-year age group population norms (Table 3; Fig. 2a,
b).
4 Discussion
Our study is important because it is the first study to
investigate the relative discriminatory power using
dimensional comparisons of all 13 individual dimensions
of the EQ-5D-5L and AQoL-8D for patients who endured
multiyear wait times in a public health system and then
underwent bariatric surgery.
As an important and emerging subgroup of bariatric
surgery patients, our cohort also delivered an important and
novel opportunity to provide clinicians with a better
understanding of the 3-month postoperative impact of
bariatric surgery on long-term waitlisted patients’ complex
physical and psychosocial domains of health.
4.1 A Head-to-Head Comparison of the EQ-5D-5L
and AQoL-8D Revisited
In support of our findings from our previously published
cross-sectional head-to-head comparison of privately trea-
ted patients who received bariatric surgery many years
previously [9], this current longitudinal study revealed that
the AQoL-8D preferentially captured and assessed the
physical and psychosocial HRQoL for our cohort of long-
term waitlisted patients who subsequently underwent bar-
iatric surgery, even 3 months after their surgery.
Amongst other direct comparisons of the discriminatory
power of the two instruments, our earlier head-to-head
study’s comparison of the patient-reported distribution of
the levels of response compared three (total six) individual
comparable dimensions of both instruments (EQ-5D-5L:
Anxiety/Depression, Self-care, Pain/Discomfort; AQoL-
8D: Mental Health, Independent Living, Pain) [9]. In
contrast, this current paper’s head-to-head comparison
conducted a longitudinal investigation for a study popula-
tion of long-term publicly waitlisted bariatric surgery
patients who underwent bariatric surgery as a targeted
government policy decision to reduce waiting lists. Com-
pared with our earlier study’s examination of six individual
dimensions, we investigated the patient-reported distribu-
tions of responses for the dimensional comparisons of all
13 individual dimensions of health for both instruments.
Consequently, this study included an additional four (of the
five) psychosocial domains of health for the AQoL-8D’s
classification system.
This current study particularly highlighted the depth and
breadth of the AQoL-8D’s classification system as com-
pared to the EQ-5D-5L. Table 2 and Appendix 1 (see the
ESM), coupled with schematic representations (Fig. 1a–c)
of the dimensional comparisons, revealed that the AQoL-
8D assessed and captured HRQoL across the broad clas-
sification system and through the levels (1 to 4–6) (there
were no reported responses for level 6 for the AQoL-8D)
given the relative dispersion of participants’ responses
away from perfect health. This is particularly highlighted
with many of the responses for the EQ-5D-5L at level 1
(perfect health/ceiling effect) and level 2, compared to the
AQoL-8D only recording just over half of the responses at
levels 1 and 2. These findings support the superior dis-
criminant sensitivity of the AQoOL-8D across the indi-
vidual dimensions of physical and psychosocial health for
the study population and as assessed in our previously
published work [9].
cFig. 1 a Distribution of participants’ responses (%) for levels (L) 1–5
for all dimensions of EQ-5D-5L and AQoL-8D before surgery and
3 months after surgery. b Distribution of participants’ responses (%)
for Levels (L) 1–5 for the combined physical dimensions of EQ-5D-
5L (Usual Activities, Self-care, Mobility, Pain) and AQoL-8D
(Independent Living, Senses, Pain) before surgery and 3 months
after surgery. c Distribution of participants’ responses (%) for Levels
(L) 1–5 for the combined psychosocial dimensions of EQ-5D-5L
(Anxiety/Depression) and AQoL-8D (Coping, Mental Health, Hap-
piness, Relationships, Self-worth) before surgery and 3 months after
surgery
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This study’s dimensional comparisons also found the
individual dimension that revealed the most similar dis-
tribution for both instruments was Pain/Discomfort (EQ-
5D-5L) and Pain (AQoL-8D). Therefore, our study’s
results suggest that both instruments were sensitive to the
individual health domain of pain for the study population.
Nevertheless, the AQoL-8D provided evidence of change
in other domains of health that could be affected by pain,
such as sleep, which impacts the Mental Health dimension.
Another key finding of our current study was that the
pre- and postoperative summary utility valuations for the
EQ-5D-5L were substantially higher (and indeed approa-
ched general population norms after surgery) than the
summary utility valuations of the AQoL-8D. The AQoL-
8D’s relatively low preoperative and 3-month postopera-
tive summary utility valuation revealed two important
findings: first, the instrument’s superior discriminant sen-
sitivity relative to the EQ-5D-5L for the study population
due to the AQoL-8D’s ability to preferentially capture
domains of health that are relevant for the study popula-
tion; and second, the substantially lower (particularly pre-
operative) HRQoL for the long-term publicly waitlisted
bariatric surgery patients. These findings also accord with
evidence that suggests in practice all MAUIs which purport
to measure utility give numerical values that differ sig-
nificantly [12, 41].
4.2 Utility Valuations
Another key finding of our current study was that change in
global utility valuations from before to 3 months after
bariatric surgery exceeded the established minimal
important differences for both instruments, and for the EQ-
VAS. The instruments’ summary utility valuations high-
lighted these long-term waitlisted bariatric surgery
patients’ considerably diminished physical and psychoso-
cial health status before surgery, and the postoperative
summary utility valuations revealed a clinical short-term
improvement within the 3-month timeframe. Nevertheless,
as discussed previously, compared to the EQ-5D-5L, the
AQoL-8D revealed substantially lower pre- and postoper-
ative utility valuations that did not approach population
norms.
In particular, this study highlighted the substantially
diminished preoperative AQoL-8D utility valuation for our
study population. To provide a comparative perspective of
the severity of our study population’s diminished health
state, a recent investigation that used data from a multi-
national (Australia, Canada, Germany, Norway, the UK
and USA) cross-sectional survey found that for composite
study populations of people with cancer or heart disease,
the AQoL-8D mean (SD) utility valuation for cancer was
0.655 (0.22), and for heart disease, it was 0.667 (0.23) [48].
Therefore, our current study’s findings particularly
revealed that the preoperative AQoL-8D utility valuation
for our cohort of severely obese long-term waitlisted
patients was over 0.15 utility points less than that for a
study population with cancer or heart disease. In other
words, people who languish for long periods on the public
waiting list can endure the same substantially diminished
HRQoL status as someone with metastatic cancer or pro-
longed heart disease.
As an independent measure of HRQoL, there is
emerging literature that suggests that utility valuations
could be independent predictors of health outcomes. A
study that investigated the predictive qualities of utility
valuations derived from the EQ-5D in patients with dia-
betes found that they were useful in predicting for health
events, including cardiovascular events (e.g. stroke, hos-
pitalisation for angina), other major diabetes-related com-
plications (e.g. heart failure, amputation, renal dialysis and
lower extremity ulcer) and death from any other cause [21].
Bariatric surgery patients carry complex physical and
psychosocial comorbidity loads, and the assessment of
utility valuations in routine clinical care could provide a
better understanding of this complexity at an individual
patient level, informing preoperative and ongoing postop-
erative care. Prediction is more likely to be accurate when
the instrument used for prediction takes account of the full
range of the complex physical and psychosocial problems
associated with the problem. Our study’s findings suggest
that the AQoL-8D is more likely to provide correct pre-
diction than the EQ-5D-5L.
4.3 AQoL-8D’s Individual and Super-Dimension
Scores
Another key finding of our current study was the substan-
tially lower AQoL-8D dimensional scores before surgery
and improvements in these dimensional levels after sur-
gery. Happiness and Coping improved the most after sur-
gery and indeed approached population norms.
Additionally, Self-worth also revealed a substantial
change. All other individual dimensions improved, but did
not substantially approach population norms. Recent evi-
dence has found that body weight is only one contributing
factor to the complex physical and psychosocial HRQoL
needs of bariatric surgery patients [8].
4.4 Integrating Patient-Reported Outcomes
in Clinical Practice
The International Society for Quality of Life Research has
developed a clinical users guide to encourage the routine
collection of PROs which ‘‘are rarely collected in routine
clinical practice’’ [49]. Recent evidence has also found that
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integrating PROs in clinical practice has the potential to
enhance patient-centred care. Within this broader and
evolving context of patient-centredness in clinical care, our
exploratory study highlighted the clinical relevance of
MAUI analyses for long-term waitlisted patients who
subsequently undergo bariatric surgery.
This study found that psychosocial health drove a rela-
tively lower utility valuation for the AQoL-8D, despite
clinical improvements. We suggest that bariatric clinicians
could also further investigate and subsequently integrate
and implement utility valuation’s predictive qualities, and
individual and super-dimension scores to further enhance
patient-centred clinical care. Further studies could assess
the feasibility of adopting a MAUI that preferentially
captures and assesses physical and psychosocial HRQoL
into the routine clinical assessment of these patients. We
previously identified in our earlier published work that the
AQoL-8D preferentially captured physical and psychoso-
cial health for patients who had undergone bariatric surgery
(in the longer term) [9], a position reinforced by our current
analysis. Through MAUI analyses, our current study
established clinically significant changes in psychosocial
health (albeit from a relatively low baseline to post-surgical
dimensional scores that were still relatively low) that
warrant additional attention after surgery to improve
overall postoperative health. Additionally, our current
study’s dimensional comparisons highlighted the EQ-5D-
5L’s relative insensitivity in distinguishing between health
states close to full (or perfect) health for long-term wait-
listed patients who had very recently undergone bariatric
surgery.
4.5 Limitations
There are limitations to our study. The first limitation is
small sample size. Nevertheless, our study was exploratory
and we were provided with a novel opportunity to recruit
participants from the long-term waitlisted patients subse-
quently fast-tracked for bariatric surgery through a gov-
ernment policy decision to reduce waiting lists. Our
exploratory study of long-term waitlisted patients should
inform larger confirmatory studies to test the validity of the
EQ-5D-5L and AQoL-8D, and the short-term health
impacts for long-term waitlisted patients. Nevertheless, we
also acknowledge that a substantial commitment would
need to be made at the public policy level to recruit a
similar cohort of long-waiting patients. Other MAUIs such
as the SF-6D could also be considered for larger confir-
matory studies. The second limitation is that all partici-
pants were operated on by the same surgeon in the same
hospital. This could affect the generalisability of our results
if scaled up to all bariatric surgery patients. On the other
hand, this circumstance could also be a strength given the
homogenous nature of the sample.
The third limitation is that there is no control arm in the
study. The observational nature of our study did not enable
the recruitment of a control arm to elicit utility valuations;
however, the key objective of this study was to compare
the two MAUI. The final limitation is that the sample is at
risk of participant selection bias, which could also affect
the generalisability of our results.
A relative strength of our study is the high overall
response rate of 74% to the questionnaires across the two
time points.
The limitations of our study concur with our comple-
mentary study of the same cohort [11].
5 Conclusions
Within the small sample limitations of our exploratory
study and to address the key objective of our study, which
was a head-to-head comparison of the instruments, com-
pared to the EQ-5D-5L, the AQoL-8D preferentially cap-
tured the complex physical and psychosocial short-term
health changes for long-term publicly waitlisted patients
who very recently underwent bariatric surgery. Impor-
tantly, researchers should understand a MAUIs descrip-
tive/classification system and the innate sensitivities of the
MAUI in regard to the particular study population, in this
case long-term waitlisted patients who then undergo bar-
iatric surgery. We recommend the AQoL-8D as a preferred
MAUI over the EQ-5D-5L for bariatric surgery patients,
given their complex physical and psychosocial needs.
In regard to our secondary objectives, utility valuations
and dimensional scores (AQoL-8D only) revealed sub-
stantially lower health status for long-term waitlisted
patients both before and after surgery, but with clinical
short-term HRQoL improvements even 3 months after
surgery. AQoL-8D preoperative utility valuation particu-
larly revealed our study population’s HRQoL was sub-
stantially lower than that of people with cancer or heart
disease.
Dimensional comparisons, utility valuations, and indi-
vidual and super-dimension scores could provide the clin-
ician with both individual patient and cohort valuations that
could lead to improved patient-centred care by identifying
health domains requiring additional attention.
Routine integration of comprehensive MAUI analyses
could provide clinicians with additional and independent
assessments and predictors of HRQoL and in turn, enhance
patient-centred care.
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